Figure 2From: Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational studyChanges in body weight and HbA1c for 2 years after liraglutide introduction. A, % Change of body weight. B, Change in HbA1c. Data are mean ± SE of 86 patients (0, 3, 6, 9, and 12 months) or 46 patients (24 months). **P < 0.01, ***P < 0.001, compared with the values at 0 month.Back to article page